955
Views
18
CrossRef citations to date
0
Altmetric
Brief Report

TLR4-dependant pro-inflammatory effects of HMGB1 on human adipocyte

, , , , , , , , & show all
Pages 384-388 | Received 20 Jul 2016, Accepted 03 Oct 2016, Published online: 28 Oct 2016

References

  • Scarpellini E, Tack J. Obesity and metabolic syndrome: an inflammatory condition. Digestive Dis 2012; 30:148-53; PMID:22722429; http://dx.doi.org/10.1159/000336664
  • Chen G, Ward MF, Sama AE, Wang H. Extracellular HMGB1 as a proinflammatory cytokine. J Interferon Cytokine Res: Off J Int Soc Int Cytokine Res 2004; 24:329-33; PMID:15212706
  • Gunasekaran MK, Viranaicken W, Girard AC, Festy F, Cesari M, Roche R, Hoareau L. Inflammation triggers high mobility group box 1 (HMGB1) secretion in adipose tissue, a potential link to obesity. Cytokine 2013; 64:103-11; PMID:23938155; http://dx.doi.org/10.1016/j.cyto.2013.07.017
  • Nativel B, Marimoutou M, Thon-Hon VG, Gunasekaran MK, Andries J, Stanislas G, Planesse C, Da Silva CR, Césari M, Iwema T, et al. Soluble HMGB1 is a novel adipokine stimulating IL-6 secretion through RAGE receptor in SW872 preadipocyte cell line: contribution to chronic inflammation in fat tissue. PloS One 2013; 8:e76039; PMID:24073286; http://dx.doi.org/10.1371/journal.pone.0076039
  • Li J, Wang H, Mason JM, Levine J, Yu M, Ulloa L, Czura CJ, Tracey KJ, Yang H. Recombinant HMGB1 with cytokine-stimulating activity. J Immunol Methods 2004; 289:211-23; PMID:15251426; http://dx.doi.org/10.1016/j.jim.2004.04.019
  • Bes-Houtman S, Roche R, Hoareau L, Gonthier MP, Festy F, Caillens H, Gasque P, Lefebvre d'Hellencourt C, Cesari M. Presence of functional TLR2 and TLR4 on human adipocytes. Histochem Cell Biol 2007; 127:131-7; PMID:16988837; http://dx.doi.org/10.1007/s00418-006-0230-1
  • Hoareau L, Bencharif K, Rondeau P, Murumalla M, Ravanan P, Tallet F, Delarue P, Cesari M, Roche R, Festy F. Signaling pathways involved in LPS induced TNFalpha production in human adipocytes. J Inflamm 2010; 7-1; PMID:20181058
  • Guzman-Ruiz R, Ortega E, Rodriguez A, Vazquez-Martinez R, Diaz-Ruiz A, Garcia-Navarro S, Giralt M, Garcia-Rios A, Cobo-Padilla D, Tinahones FJ, et al. Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in beta-cells. Int J Obesity 2014; 38:1545-54; PMID:24577317; http://dx.doi.org/10.1038/ijo.2014.36
  • Arrigo T, Chirico V, Salpietro V, Munafo C, Ferrau V, Gitto E, Lacquaniti A, Salpietro C. High mobility-group protein B1: a new biomarker of metabolic syndrome in obese children. Eur Endocrinol / Eur Federatf Endocrine Soc 2013; 168:631-8; PMID:23384711
  • Giaccobe A, Grasso R, Imbesi G, Salpietro CD, Grasso L, Lagana AS, Triolo O, Di Benedetto A. High mobility group protein B1: a new biomarker of obesity in pregnant women? Gynecol Endocrinol: Off J Int Soc Gynecol Endocrinol 2014; 1-3
  • Lappalainen T, Kolehmainen M, Schwab U, Pulkkinen L, de Mello VD, Vaittinen M, Laaksonen DE, Poutanen K, Uusitupa M, Gylling H. Gene expression of FTO in human subcutaneous adipose tissue, peripheral blood mononuclear cells and adipocyte cell line. J Nutrigenet Nutrigenomics 2010; 3:37-45; PMID:20948226; http://dx.doi.org/10.1159/000320732
  • Wagner M. A dangerous duo in adipose tissue: high-mobility group box 1 protein and macrophages. Yale J Biol Med 2014; 87:127-33; PMID:24910558
  • Yang H, Wang H, Ju Z, Ragab AA, Lundback P, Long W, Valdes-Ferrer SI, He M, Pribis JP, Li J, et al. MD-2 is required for disulfide HMGB1-dependant TLR4 signaling. J Exp Med 2015; 212:5-14; PMID:25559892; http://dx.doi.org/10.1084/jem.20141318
  • Schiraldi M, Raucci A, Munoz LM, Livoti E, Celona B, Venereau E, Apuzzo T, De Marchis F, Pedotti M, Bachi A, et al. HMGB1 promotes recruitment of inflammatory cells to damage tissues by forming a complex with CXCL12 and signaling via CXCR4. J Exp Med 2012; 209:551-63; PMID:22370717; http://dx.doi.org/10.1084/jem.20111739
  • Nogueira-Machado JA, Volpe CM, Veloso CA, Chaves MM. HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation. Expert Opin Therap Targets 2011; 15:1023-35; PMID:21585289; http://dx.doi.org/10.1517/14728222.2011.575360
  • Yang H, Lundback P, Ottosson L, Erlandsson-Harris H, Venereau E, Bianchi ME, Al-Abed Y, Andersson U, Tracey KJ, Antoine DJ. Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol Med 2012; 18:250-9; PMID:22105604; http://dx.doi.org/10.2119/molmed.2011.00389

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.